MAZE Q1 2026 Earnings EPS Surprises to the Upside Revenue Yet to Materialize C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage ONCY Q3 2025 Earnings WiderthanExpected Loss Amid Clinical Progress Sphere 3D Corp ANY Q4 2025 Earnings NarrowerThanExpected Loss Yet Shares Dip 2 DNUT Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh on Performance SWMR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Surges 139